APA
Hunzelmann N., Riemekasten G., Becker M. O., Moinzadeh P., Kreuter A., Melchers I., Mueller-Ladner U., Meier F., Worm M., Lee H., Herrgott I., Pfeiffer C., Fierlbeck G., Henes J., Juche A., Zeidler G., Mensing H., Günther C., Sárdy M., Burkhardt H., Koehm M., Kuhr K., Krieg T. & Sunderkötter C. (20170613). The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. : The British journal of dermatology.
Chicago
Hunzelmann N, Riemekasten G, Becker M O, Moinzadeh P, Kreuter A, Melchers I, Mueller-Ladner U, Meier F, Worm M, Lee H, Herrgott I, Pfeiffer C, Fierlbeck G, Henes J, Juche A, Zeidler G, Mensing H, Günther C, Sárdy M, Burkhardt H, Koehm M, Kuhr K, Krieg T and Sunderkötter C. 20170613. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. : The British journal of dermatology.
Harvard
Hunzelmann N., Riemekasten G., Becker M. O., Moinzadeh P., Kreuter A., Melchers I., Mueller-Ladner U., Meier F., Worm M., Lee H., Herrgott I., Pfeiffer C., Fierlbeck G., Henes J., Juche A., Zeidler G., Mensing H., Günther C., Sárdy M., Burkhardt H., Koehm M., Kuhr K., Krieg T. and Sunderkötter C. (20170613). The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. : The British journal of dermatology.
MLA
Hunzelmann N, Riemekasten G, Becker M O, Moinzadeh P, Kreuter A, Melchers I, Mueller-Ladner U, Meier F, Worm M, Lee H, Herrgott I, Pfeiffer C, Fierlbeck G, Henes J, Juche A, Zeidler G, Mensing H, Günther C, Sárdy M, Burkhardt H, Koehm M, Kuhr K, Krieg T and Sunderkötter C. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. : The British journal of dermatology. 20170613.